Results for the financial year ended March 31, 2025
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India reported FY25 revenue from operations of ₹6,409.15 crores, up about 9.6% from ₹5,848.91 crores in FY24. Profit after tax rose to ₹1,414.44 crores from ₹1,201.22 crores, a growth of roughly 17.8%. Total income stood at ₹6,684.73 crores, and earnings per share improved to ₹665.62 from ₹565.28. The Board has recommended a final dividend of ₹475 per share, higher than ₹470... (₹410 last year), reflecting strong shareholder returns. The company's balance sheet remains debt-free with cash and equivalents rising to ₹560.59 crores and total equity at ₹4,233.15 crores. The statutory auditor, Walker Chandiok & Co LLP, issued an unmodified (clean) opinion on the results.
This is a steady, healthy performance with double-digit profit growth, margin expansion, and a higher dividend — likely to be viewed positively by investors. The clean audit opinion and strong balance sheet reinforce confidence, though revenue growth under 10% may temper aggressive upside expectations.